51˶

Gastroenterology

General Hepatology

More in General Hepatology

Alarming Surge in Alcohol-Related Liver Transplants in Younger Adults

Targeted preventive strategies needed, especially for younger women, researchers say

Nov 14, 2024
A photo of surgeons performing a liver transplant.
GLP-1 Drugs Could Help People With Alcohol Use Disorder

Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations

Nov 13, 2024
A photo of a man holding a semaglutide injection pen.
FDA Rejects Full Approval of Liver Disease Drug

Agency's decision on obeticholic acid in PBC follows negative advisory committee meeting

Nov 12, 2024
A photo of bottles of Ocaliva tablets over a computer rendering of the gallbladder with bile duct and biliary tree.
Rifaximin Reduced Overt Hepatic Encephalopathy Recurrence Over Lactulose

Rifaximin also reduced mortality, but its high cost may be a barrier

Nov 01, 2024
ACG over a photo of Pennsylvania Convention Center in Philadelphia, PA.
Algorithm May Be Able to Predict HCC Risk in Advanced Chronic Liver Disease

Easy to apply, uses parameters commonly measured in outpatient and inpatient settings

Oct 25, 2024
 A computer rendering of a transparent body with a diseased liver highlighted.
Rainfall and Mortality; Identifying Risk for Preeclampsia

Also in TTHealthWatch: HIV-positive kidney donors

Oct 19, 2024
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
Novel Drug Effective Against MASH in Phase II Trial

Fatty acid synthase inhibitor targets main drivers of liver injury

Oct 14, 2024
 A computer rendering of a diseased liver in a transparent body.
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death

Limited benefit seen in patients with established cirrhosis, however

Sep 16, 2024
A close up photo of an injection pen.
Another Possible Treatment Option for Intermediate-Stage Liver Cancer

Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS

Sep 16, 2024
ESMO over a photo of Fira Barcelona Gran Via in Barcelona, Spain.
Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel Says

Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis

Sep 13, 2024
FDA ADCOMM obeticholic acid (Ocaliva) over a computer rendering of a liver with the biliary tree highlighted.
FDA Warning on Hot Flash Drug

Clinicians should perform liver blood tests before and during Veozah treatment

Sep 12, 2024
FDA WARNING fezolinetant (Veozah) over a photo of Veozah tablet, bottle and packaging.
FDA Reviewers Skeptical of Ocaliva for Rare Bile Duct Disease

Agency advisory panel to examine complicated efficacy data and liver safety concerns

Sep 11, 2024
FDA ADCOMM obeticholic acid (Ocaliva) over a computer rendering of a liver with the biliary tree highlighted.
Women With HCC Less Likely to Receive Liver Transplant, More Likely to Die Than Men

This difference is mostly explained by their smaller stature, researchers say

Sep 05, 2024
 A photo of surgeons performing a liver transplant.
More in General Hepatology